Reid Perper

Chief Investment Officer at Five Arrows Managers (USA) LLC

Reid Perper

Reid Perper

Chief Investment Officer at Five Arrows Managers (USA) LLC

Overview
Career Highlights

Five Arrows Managers (USA) LLC
MCT Advisors LLP

RelSci Relationships

550

Number of Boards

4

Birthday

1960

Age

59

Contact Data
Trying to get in touch with Reid Perper? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Reid Perper likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Partner & Co-Chief Executive Officer at Avista Capital Partners

Relationship likelihood: Strong

Chief Executive Officer at Charles River Laboratories, Inc.

Relationship likelihood: Strong

Special Limited Partner at Catalyst Healthcare Ventures

Relationship likelihood: Strong

Former Chief Executive Officer at Bausch + Lomb, Inc.

Relationship likelihood: Strong

Former Chief Financial Officer & Senior Vice President at Honeywell International, Inc.

Relationship likelihood: Strong

Former Chairman & Chief Executive Officer at Smithkline Beckman Corp.

Relationship likelihood: Strong

Senior Member of the Advisory Board at Johnson & Johnson

Relationship likelihood: Strong

Founder at Agios Pharmaceuticals, Inc.

Relationship likelihood: Strong

Founder at NxStage Medical, Inc.

Relationship likelihood: Strong

Executive Officer at Heartland Water Technology, Inc.

Relationship likelihood: Strong

Paths to Reid Perper
Potential Connections via
Relationship Science
You
Reid Perper
Chief Investment Officer at Five Arrows Managers (USA) LLC
Education

The University of Pennsylvania (commonly referred to as Penn or UPenn) is a private, Ivy League university, located in Philadelphia, Pennsylvania, United States. Penn considers itself the fourth-oldest institution of higher education in the United States, as well as the first university in the United States with both undergraduate and graduate studies.

Stanford University, located between San Francisco and San Jose in the heart of California's Silicon Valley, is one of the world's leading teaching and research universities. Since its opening in 1891, Stanford has been dedicated to finding solutions to big challenges and to preparing students for leadership in a complex world.

Career History
Chief Investment Officer
2017 - Current
Senior Advisor
Current

Health Evolution Management focuses on long-term investments in healthcare companies that provide services, technologies and information solutions that improve the delivery, organization and financing of healthcare.The Health Evolution Partners Growth and Buyout Fund is a $500 million fund that invests in late stage healthcare companies. The fund focuses on investments in successful companies that have the potential to become market leaders and to improve value to end users. The fund makes growth and late stage investments in companies that are EBITDA positive or that have a demonstrated pathway to EBITDA growth. Investments may take the form of expansion capital, recapitalizations, buyouts, spin-offs and other forms of late stage financing. Health Evolution Management focuses on companies with sustainable competitive advantages, strong management teams and proprietary healthcare technology and processes. Initial equity investments range from $20 million to $80 million.Health Evolution Management developed the Health Evolution Partners Innovation Network (HEPIN), a $200 million fund supported by a partnership between the firm and a small number of early-stage venture capital funds. Partner funds work with Health Evolution Management to move innovations from idea to proof-of-concept and to develop leading management teams of the future. Health Evolution Management invests directly in portfolio companies and also invests into partnered venture funds.The firm's direct investments in portfolio companies take the form of lead investments and co-investments with HEPIN fund partners. Health Evolution Management may also invest in syndication with other funds. The firm seeks to invest in healthcare services, technology, diagnostics and medical devices that have the potential to establish a leadership position in a niche market, become the foundation for a solution platform or offer an innovation or disruption that can be integrated into an existing solution platform. They prefer to invest in opportunities in which significant engineering, science and regulatory risk does not exist. The firm also prefers to invest in companies operating in large markets with favorable growth trends and supportive regulatory and reimbursement environments. Health Evolution Management plays an active role in their investments taking board seats with all lead investments and at least board observation rights with co-investments. Initial equity investments range from $5 million to $10 million with capital reserved to maintain the firm's pro rata ownership.

Senior Advisor, Growth Buyout Fund
Current
Boards & Committees
Director
Current

Charles River Laboratories, Inc. provides research models and laboratory animal support services. It offers quality research models and support services to the biomedical community. The company is headquartered in Wilmington, MA.

Member, Board of Directors
Current

Kisimul School Holdings Ltd. is a British company, with subsidiaries in the United Kingdom, that operates as a holding company.The company says this about itself: The principal activity of the company is that of a holding company within the Group, a Group headed by Cedar Project Holdco Limited. The principal activity of the company's subsidiaries is that of the provision of education and care to people with severe learning disabilities and challenging behaviour.

Independent Director
2005 - 2019

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success – is inspiring patients and providers. We’re not working alone. Part of our success has come through working closely with customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care. Our ultimate purpose is to improve the lives of renal patients, and our approach is already resulting in changed lives and industry improvements. Together, we’re changing traditional perceptions of how renal care can be delivered. NxStage innovations are expanding and improving treatment options – and giving patients and caregivers the ease and flexibility to perform treatment when they want, where they want, and how they want. We found the future of renal care because we looked for it. Thanks to forward-thinking care partners, patients, and NxStage inventors and engineers, a new era has arrived. This is great news for the estimated 2 million people around the world suffering from chronic kidney failure, or End-Stage Renal Disease (ESRD) including 571,414 in the U.S.1 It’s also good news for the hundreds of thousands of patients every year in the U.S. who suffer from acute kidney failure due to surgery, trauma, poisoning, or other emergent health situations.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Reid Perper. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Reid Perper's profile does not indicate a business or promotional relationship of any kind between RelSci and Reid Perper.